tridecactide
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Nov 4, 2018 (NCT03283397)
Timeline
Indications
Mechanism of action
- Pro-opiomelanocortinSupplementation
POMC supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108340 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04374032 | Phase 2/Phase 3 (Phase 3) | May 1, 2020 | Kocaeli University |
| NCT03283397 | Phase 3 | Nov 4, 2018 | Kocaeli University, MonitorCRO |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kocaeli University | Academic/Hospital | 2 | 2 | 1 | 2018 |
| MonitorCRO | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1